sub-populations, which are significantly enriched for cells expressing key naïve pluripotency regulatory genes and genetic markers of all three major lineages created during human blastocyst differentiation. Results of our analyses suggest that during early stages of preimplantation embryogenesis putative immortal multi-lineage precursor cells (iMPCs) are created, which then differentiate into trophectoderm, primitive endoderm and pluripotent epiblast lineages. We propose that cellular extinction events in cleavage-stage embryos are triggered by premature activation of HPAT lincRNAs reflecting failed iMPC's creation attempts.
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Summary
Chromosome instability and aneuploidies occur very frequently in human embryos, impairing proper embryogenesis and leading to cell cycle arrest, loss of cell viability, and developmental failures in 50-80% of cleavage-stage embryos. This high frequency of cellular extinction events represents a significant experimental obstacle challenging analyses of individual cells isolated from human preimplantation embryos. Here, we carried out single cell expression profiling analyses of 241 individual cells recovered from 32 human embryos during the early and late stages of viable human blastocyst differentiation. Classification of embryonic cells was performed solely based on expression patterns of human pluripotency-associated transcripts (HPAT), which represent a family of transposable element-derived lincRNAs highly expressed in human embryonic stem cells (hESCs) and regulating nuclear reprogramming and pluripotency induction. We then validated our findings by analyzing 1,708 individual embryonic cells recovered from more than 100 human embryos and 259 mouse embryonic cells at different stages of preimplantation embryogenesis. Our experiments demonstrate that segregation of human blastocyst cells into distinct sub-populations based on single-cell expression profiling of just three HPATs (HPAT-21; -2; and -15) appears to inform key molecular and cellular events of naïve pluripotency induction and accurately captures a full spectrum of cellular diversity during human blastocyst differentiation. HPAT's expression-guided spatiotemporal reconstruction of human embryonic development inferred from single-cell expression analysis of viable blastocyst differentiation enabled identification of TERT (+) sub-populations, which are significantly enriched for cells expressing key naïve pluripotency regulatory genes and genetic markers of all three major lineages created during human blastocyst differentiation. Results of our analyses suggest that during early stages of preimplantation embryogenesis putative immortal multi-lineage precursor cells (iMPCs) are created, which then differentiate into trophectoderm, primitive endoderm and pluripotent epiblast lineages. We propose that cellular extinction events in cleavage-stage embryos are triggered by premature activation of HPAT lincRNAs reflecting failed iMPC's creation attempts.
Introduction
Precise spatio-temporal activation of species-specific transposable elements (TrE), and particularly of regulatory sequences derived from human endogenous retroviruses (HERVs), have been associated with the induction and maintenance of human pluripotency, functional identity and integrity of naïve-state embryonic stem cells, and anti-viral resistance of the early-stage human embryos [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . These studies identified long intergenic non-coding RNAs (lincRNAs) derived from HERVs as the reliable genetic markers and critically important regulators of the pluripotent state in human cells [8; 14; 15; 17] . Active expression of lincRNAs encoded by specific HERVs is required for pluripotency maintenance in hESC [8; 17] and plays essential functional roles in naïve-like hESC [15; 16] , development of human preimplantation embryos [16; 17] , and pluripotency induction during nuclear reprogramming [9; 10; 15; 17] . Individual members of one functionally and structurally-related family of TrE-derived lincRNAs, which are highly expressed in hESC and termed human pluripotency-associated transcripts (HPATs), have been shown to affect the regulation of nuclear reprogramming and pluripotency induction during preimplantation embryogenesis [17] . Despite this significant progress facilitated by single-cell analyses of hESCs and human embryos, our understanding of how the earliest lineage commitments are regulated and individual cell fate decisions are executed remains limited. In particular, the expression dynamics and biological roles of TrE-derived lincRNAs in these processes are not fully understood.
Several methodological hurdles and fundamental problems complicate the analysis of human preimplantation embryogenesis. Chromosome instability is common in the early-stage human embryonic development and aneuploidies are observed in 50-80% of cleavage-stage human embryos leading to cell cycle arrest, impaired viability of embryonic cells' and developmental failures [19] [20] [21] [22] [23] . Therefore, without the application of reliable prospective controls of the viability of human embryonic cells, the likelihood of studying a significant fraction of dying human embryonic cells is high and should approach the 50 -80% probability. A systematic application of non-invasive assays that accurately predict the likelihood of viable blastocyst development during evaluation of the mature oocytes and/or zygotes should help to address this limitation. It has been shown that the analysis of zygote viscoelastic properties as well as cytokinesis timing in the early 5 stages of human embryo development can predict viable blastocyst formation with >90% precision, 95% specificity and 75% sensitivity [23; 46] . Another potentially significant limitation of single cell studies of human embryos is the use of the timeline after fertilization as end-point for isolating individual human embryonic cells.
This approach would likely generate developmentally heterogeneous mixes of single cells isolated from human embryos that are not fully synchronized and will have varying proportions of dying versus viable cells at any given developmental time point.
To address these limitations, we implemented an experimental approach ensuring the high likelihood of studying truly viable human embryonic cells and employing the strict morphological criteria for segregation of viable blastocyst cells into the early and late blastocyst developmental stages defined by classic embryological criteria [18] . Using this approach, single-cell gene expression profiling was successfully carried-out in 241 individual cells recovered from early and late human blastocysts to delineate the spatiotemporal dynamics of gene expression changes during human blastocyst differentiation [18] . This experimental system faithfully distinguished all three lineages that form the human blastocyst and facilitated development of a threedimensional in silico model of the inner cell mass and trophectoderm, in which individual cells were mapped into distinct expression domains corresponding to the lineage differentiation in human blastocysts [18] . This in situ model was then used to design the first web-based online tool to study early cell fate decisions in the human blastocyst, which is available online at http://web.stanford.edu/~sunilpai/HumanBlastocystViewer.html (Firefox/Chrome compatible).
Here, we utilized this experimental system to perform analysis of TrE-derived lincRNAs within the context of the high-complexity single-cell expression profiling matrix comprising more than 20,000 features and capturing the expression of 89 genes in 241 individual cells recovered from early and late differentiation stages of viable human blastocysts. We validated our experimental findings and novel mechanistic models by in silico gene expression profiling analyses of four independent validation data sets comprising of 1,708 individual embryonic cells recovered from more than 100 human embryos at different stages of preimplantation embryogenesis [12; 13; 34; 44}. The major novel observations reported in this contribution are:
Our experiments identify five most abundant HPATs (HPAT21/15/5/2;3) which were detected in 25% to 97% of viable human blastocyst cells;
ii)
We demonstrate that segregation of human blastocyst cells into distinct sub-populations based on a single-cell expression profiling of just three HPATs (HPAT21/2/15) appears to inform key molecular and cellular events of naïve pluripotency induction and accurately captures the entire spectrum of cellular diversity during human blastocyst differentiation;
iii) We observe that during human embryogenesis, telomerase-positive multi-lineage precursor cells are created to then differentiate into trophectoderm, primitive endoderm and pluripotent epiblast lineages.
Results
HPAT lincRNA expression-guided classification of human blastocyst cells
Using a hybrid RNA sequencing technique we have previously identified and characterized 23 novel TrEderived lincRNAs that are highly expressed in hESC and termed human pluripotency-associated transcripts (HPATs) [17; 36] . We have developed and implemented qPCR-based assays for sixteen HPATs [17; 18] and thought to begin our analytical effort by focusing on the exploration of the expression patterns of these sixteen TrE-derived lincRNAs during human blastocyst differentiation (Fig. 1 ). This analysis identifies five TrE-derived lincRNAs (HPAT21; HPAT15; HPAT5; HPAT2; and HPAT3) which were observed most frequently and detected in at least 25% of analyzed human blastocyst cells (Supplemental Fig. S1 ). Notably, three out of these five lincRNAs were recently implicated in regulation of nuclear reprogramming and pluripotency induction during human preimplantation embryo development [17] . Expression of HPAT21, the most abundant lincRNA, was detected in 92% of cells recovered from the early blastocysts and 100% of the late blastocyst cells, whereas expression of the second-ranked lincRNA HPAT15 was observed in 56% and 48% of the early and late blastocyst cells, respectively. Notably, the expression patterns of the vast majority (94%) of lincRNAs did not manifest significant changes in the early and late blastocyst cells (Supplemental Fig. S1 ), indicating that (Fig. 1B) . The results of the present analyses suggest that expression profiles of just three lincRNAs capture a full spectrum of cellular phenotypes created during differentiation of human blastocysts. It was of interest to determine whether detailed analysis of sub-populations of cells defined by the expression patterns of these 3 genetic markers would inform events of naïve pluripotency induction and faithfully describe the evolution of cellular diversity during human blastocyst differentiation. (Fig. 1E) .
Single
Analysis of expression profiles of genetic markers of distinct lineages created during human blastocyst differentiation
In contrast to the HPAT2pos cells, we observed clear evidence that other HPAT's expression-defined subpopulations appear to display the gene expression changes which were previously identified as genetic elements of distinct differentiation programs during the human blastocyst development (Fig. 2) . The validity of the proposed lineage assignments to the HPAT expression-defined sub-populations in human blastocyst were assessed using single-cell expression profiling data of genes specifically expressed in the trophectoderm (TROP2, CDX2, TEAD4); expression profiling of known markers of the pluripotent epiblast (LIN28A and TDGF1) and known markers of primitive endoderm (GRB2 and GATA4) [24] [25] [26] as well as additional sets of the human blastocyst lineage-specific genetic markers identified in the recent study [18] . It has been documented that primitive endoderm (PE) cells express high levels of the FGFR2 and low levels of the GATA4 1 0
at the early-stage blastocyst differentiation [18] . During the transition from the early to late blastocyst stages, Previous analyses demonstrate that cells expressing genetic markers of the pluripotent epiblasts are significantly enriched within the HPAT2pos sub-populations ( Fig. 1) . Strikingly, analysis of expression patterns of lineage-specific markers in HPAT expression-defined sub-populations recovered from late-stage human blastocysts revealed that cells expressing multiple markers of both TE and PE lineages appear significantly more prevalent among the HPAT2pos sub-populations (Fig. 2D ). These results demonstrate that HPAT2pos cells express markers of all three major lineages created during blastocyst differentiation (Fig. 2D ).
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Collectively, our observations strongly argue that during human blastocyst differentiation, the unique subpopulation of HPAT2pos human embryonic cells is created that could be defined as putative multi-lineage precursor cells. It is tempting to speculate that subsequent specialization and differentiation of HPAT2pos cells fuels the emergence of the trophectoderm, primitive endoderm and epiblast lineages.
Expression patterns of human naïve pluripotency regulatory genes during human blastocyst differentiation
Several recent studies reported identification of genes that play essential role in induction, reset, and/or maintenance of the naïve pluripotent state in human cells [18; 30-32] . Forced expression of these genes induce or reset the naïve pluripotent state in human cells whereas their targeted silencing markedly affect the naïve pluripotency phenotypes. We observed that blastocyst cells expressing the genes encoding all these naïve pluripotency inducers are markedly enriched within the HPAT2pos sub-populations ( 
Single-cell expression profiling of genomic loci encoding HPAT lincRNAs during preimplantation development of human embryos
To further test the hypothesis that HPAT2pos sub-populations harbor putative multi-lineage precursor cells, we thought to carry-out single-cell expression profiling analyses during human preimplantation development of TrE-derived lincRNAs, including expression of two HERVH-derived lincRNAs (HPAT2 and HPAT3), which appears markedly enriched in HPAT2pos blastocyst cells (Figs. 2 & 3) . Significantly, three of five most abundant lincRNAs (HPAT2; HPAT3; and HPAT5) in human blastocysts were previously implicated in regulation of nuclear reprogramming and pluripotency induction [17] . We reasoned that if the proposed model is valid, the high expression levels of these lincRNAs should be observed in late blastocysts, epiblast cells, and naïve hESCs. To this end, we ascertained the expression profiles of HERV-loci of the human blastocyst HPAT lincRNAs in 153 individual human embryonic cells of the Yan et al. [13] and Xue et al [12] validation data sets (Supplemental Table S1 ). sub-population-based profiles plotted as mean expression values (Fig. 4A-E ) and expression profiles of 153 individual human embryonic cells at various stages of preimplantation embryogenesis ( Fig. 4F-I ).
We noted that individual human embryonic cells manifesting low expression of TrE-derived lincRNA are detectable throughout the preimplantation embryo development, including the late blastocyst stage.
Intriguingly, some TrE-derived lincRNAs manifest clearly distinct expression patterns in naïve hESCs (designated as hESCp0 in Fig. 4 ) compared with cultured hESCs (designated as hESCp10 in Fig. 4 ). Individual human embryonic cells with the highest expression of the HPAT3 lincRNA appear at the late blastocyst stage; they represent all naïve hESCp0 cells, and their prevalence is markedly diminished in population of cultured hESCp10 cells (Fig. 4I ). High HPAT2-expressing cells appear in the hESC population: they comprise approximately half of the naïve hESCp0 population and continue to persist as a major sub-population in hESCp10 cultures (Fig. 4H ). Taken together, these results provide additional strong arguments supporting the validity of our proposed model and indicating that the HPAT2pos cells may serve as a putative precursor of naïve hESCs.
Identification and characterization of putative immortal multi-lineage precursor cells (iMPC) recovered from viable human blastocysts
We reasoned that the multi-lineage precursor cell population may be found among potentially immortal sub- roles during the embryonic development [17] and support the idea that HPAT2pos sub-populations of human blastocysts contain putative immortal multi-lineage precursor cells (iMPCs).
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Single cell analysis of TERT expression dynamics in human preimplantation embryos revealed a timeline of emergence and sustained presence of putative iMPCs
We carried out a series of follow-up analyses to identify human embryonic cells resembling the putative iMPCs among individual cells and distinct lineages which were identified and characterized in a recently reported independent data set of single cell expression profiles of 1,529 embryonic cells recovered from 88 human embryos at different stages of preimplantation embryonic development [34] . To this end, we evaluated TERT mRNA expression patterns in each of the 1,529 individual human embryonic cells that were recovered at different stages of preimplantation embryogenesis and assigned to distinct lineages based on their gene expression (Supplemental Figure S4 ). These analyses demonstrate that TERT (+) cells could be observed among all lineages and are readily detectable as early as at E3-E4 stages followed by the expansion during the E5 stage coincidently with blastocyst formation (Supplemental Figure S4) . We found that E5 pre-lineage cells manifest significantly increased levels of TERT mRNA expression compared to EPI, PE, and TE lineages (Supplemental Figure S4) . Interestingly, the second peak of TERT activity was observed at the E6 in all three major lineages created during human preimplantation embryonic development. We observed that the E5.early cell population has the highest level of TERT mRNA expression and contains the largest percentage of TERT (Fig. 6) .
Importantly, the iMPC-resembling cells are represented most prominently among E5 pre-lineage cells and
.early cells of the Petropolous et al. study (Fig. 6B) . In striking contrast, the population of TERT
E3 cells does not appear to contain iMPC-like cells (Fig. 6B ). This conclusion remains valid when observations were made employing the population-based approach by comparing either the lineage-defined or embryonic stage-defined populations (Fig. 6 ).
We thought to extend these population-based observations by performing the analyses of individual embryonic stage-defined populations (Fig. 6B) , there were no iMPC-like individual cells detectable at the E3 stage (Fig. 6D) . We observed that individual iMPC-resembling cells emerged among human embryonic cells at the E4.early stage and persisted throughout E4-E7 stages of human embryonic development (Fig. 6D) . The largest percentage of the iMPC-resembling cells was observed among the TERT (+) E5.early cells (Fig. 6D) .
Using this strategy, we identified 158 TERT (+) human embryonic cells in the Petropolous et al. data set, which recapitulate the 46-gene expression profile of the iMPCs (Figs. 6C & 6D) . Furthermore, our analyses identify the E5 pre-lineage cells and the E5.early TERT (+) cells as sub-populations of human embryonic cells that appears most enriched for iMPC-like cells. Therefore, it seems reasonable to conclude that these analyses demonstrate a consistent presence of iMPC-resembling cells in human preimplantation embryos.
Genome-wide screens of single-cell expression profiles of embryonic cells identifies consensus gene expression signatures of the iMPCs in human and mouse embryos
To further test the validity of our hypothesis that iMPCs are created during human preimplantation embryogenesis, we carried-out several additional follow-up analytical experiments. We performed the formal statistical analysis to determine whether the expression levels of the forty six genes comprising the iMPC gene expression signature are statistically different in 158 TERT (+) top-scoring TERT (+) iMPC-like embryonic cells in two independent validation data sets comprising 1,529 and 124 individual human embryonic cells and designated as validation data set 1 and 2, respectively (Supplemental Table S1 ; refs. 34 & 13).
Next, the similarity patterns of gene expression signatures (GES) defining putative immortal multilineage precursor cells were ascertained by comparisons of three populations of iMPCs which were independently identified in the Stanford discovery data set ( Fig. 6F; expression signature of TERT (+) iMPC of human embryos comprising 241 up-regulated and 622 downregulated genes (Fig. 6G) . Notably, the genomic origin of a majority (82.9%) of down-regulated genes of the consensus TERT (+) iMPC expression signature could be traced to the maternal genome ( Fig. 6G ; red bars in the bottom right image), suggesting that the efficient transcriptional repression of maternally-expressed genes represents one of the key features of the iMPC population. In striking contrast, the genomic origin of a vast majority (87.6%) of up-regulated genes could be traced to the embryonic genome ( Fig. 6G ; blue bars in the bottom right image), indicating that genes transcriptionally active in the embryonic genome make a significant contribution to the creation of the TERT (+) iMPC in human embryos.
We thought to employ the 23-gene expression signature of TERT (+) iMPC-like cells of human embryos to identify the putative iMPC-like cells during the mouse preimplantation embryogenesis [45] . Analysis of gene expression profiles of 259 mouse embryonic cells (mouse embryo validation data set; Supplemental Table S1) identifies top-scoring TERT (+) iMPC-like mouse embryonic cells comprising 5% of mouse embryonic cells.
Using genome-wide statistical screens of single-cell gene expression profiling of embryonic cells, we were able to identify individual iMPC-like cells in a data set which were assigned to the particular stages of human and mouse embryonic development. Using these data and reported numbers of analyzed embryonic cells assigned to the corresponding embryogenesis stage in a data set, we estimated the likelihood of emergence and expected creation timelines of the TERT (+) iMPC in individual human and mouse embryos (Fig. 6H ). We In striking contrast, biological processes that are significantly enriched among genes down-regulated in iMPCs appear linked with cellular differentiation and fine specialization of differentiated cells (Supplemental Figure S5 ). They were defined by gene ontology analysis as processes of cell adhesion, biological adhesion, cell motion, cell motility, localization of cells, regulation of response to external stimulus, cell migration, response to wounding, and gland development. Collectively, these results are highly consistent with observations that iMPCs represent a transitory cell type during embryogenesis (Fig. 6H ) that differentiate into trophectoderm, primitive endoderm and pluripotent epiblast lineages.
Discussion
The novel elements of the experimental approach implemented in this study are based on the isolation of viable human blastocysts and separation of the human blastocyst cells into early and late blastocyst cell populations based on strict morphological criteria defined by the classic embryology. We believe that this approach provides a more stringent basis to control human embryonic cells' viability. High level of certainty that we analyzed the viable human embryonic cells should mitigate potential limitations of previous studies utilizing the single cell expression profiling approaches of the analysis of human preimplantation embryogenesis and relying solely on segregation of individual cells based on the time after fertilization. One of the obvious flaws of this timeline-based approach is that integration of the single cell analyses from different human embryos would inevitably generate the developmentally heterogeneous sub-populations simply because the lack of synchronization of embryonic development among individual human embryos.
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Application of this experimental approach in combination with the state-of-the-art single cell gene expression analysis and spatiotemporal reconstruction of human blastocyst differentiation facilitated the development of a three-dimensional model of the inner cell mass and trophectoderm in which individual cells were faithfully mapped into distinct expression domains [18] . Using this approach, we were able to extract and describe the key novel mechanistic information emanated by the single-cell expression analyses of proteincoding genes [18] . Specifically, these experiments revealed a previously uncharacterized role for MCRS1, TET1, and THAP11 in epiblast formation and their ability to induce naive pluripotency in vitro.
Remarkably, the single cell expression profiling analysis of human blastocyst differentiation based solely on the TrE-derived lincRNAs expression profiles facilitated a series of novel observations potentially leading to significant conceptual advances in our understanding of genetic, molecular, and cellular mechanisms of human preimplantation embryonic development. Identification and characterization of putative iMPCs highlighted a key role of MTTH/HPAT lincRNAs regulatory axis in a two-wave progression sequence of human embryonic development (Fig. 6I) . Significantly, sequence conservation analyses of HPAT lincRNAs, expression profiling of which facilitated identification of putative iMPCs, indicated that they represent humanspecific (unique to human) regulatory molecules (data not shown). A hallmark feature of human-specific integration sites of stem cell-associated retroviral sequences, including specific HPAT lincRNAs, is deletions of ancestral DNA [35] .
It has been shown that activation of specific HERV loci, including HPAT3 and HPAT4 lincRNAs, occurs in human zygotes following in vitro fertilization of mature oocytes [47] . Gene expression signature analysis of early-stage human preimplantation embryogenesis revealed that "premature" activation of HERVH expression is associated with increased likelihood of failure to produce viable blastocysts by human fertilized oocytes [47].
These observations support the hypothesis that premature activation of HERV expression in early-stage human embryos may reflect failed attempts to create iMPCs. Collectively, this analysis suggests that premature activation of HERV expression in human embryonic cells may cause cell cycle arrest and loss of cell viability, leading to exceedingly high level of cellular extinction events.
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Observations supporting the hypothesis that putative iMPCs are created during the human blastocysts human pluripotent cells [17] . It has been demonstrated that three specific TrE-derived HPAT lincRNAs (HPAT2, HPAT3 and HPAT5) may modulate cell fate in human preimplantation embryo development and during nuclear reprogramming [17] . Our experiments identified five most abundant HPATs (HPAT21; HPAT15; HPAT5; HPAT2; and HPAT3) expression of which was observed most frequently in human blastocyst cells.
Expression of the HPAT21 lincRNA was detected in 92% and 100% of cells recovered from early and late stage-developing blastocysts, respectively, suggesting that this lincRNA could be defined as the pan marker of human blastocyst cells.
The conclusive unequivocal validation of the hypothesis that during human blastocyst differentiation the unique sub-populations of putative iMPCs are created, which fuels the emergence of the trophectoderm, primitive endoderm and epiblast lineages, and induction of the naïve hESCs, may prove challenging since it would require the direct isolation and recovery of these unique cells from the human blastocysts and their comprehensive molecular and functional characterization. However, our observations that expression of HPAT lincRNAs implicated in human blastocyst differentiation is markedly up-regulated in human cells acquiring the 2 5 genetically-induced naïve pluripotency state suggest that it might be possible to design the experimental protocols for genetic engineering of the iMPC-resembling cells. It will be of interest to investigate the developmental potential and translational utility of iMPCs for regenerative medicine.
Collectively, our observations demonstrate that during preimplantation embryogenesis the iMPCs are 
Experimental Procedures Human blastocyst retrieval and disaggregation into single cells
Frozen human blastocysts at day 5 and day 6 post fertilization of preimplantation development were thawed according to Quinn's advantage thaw kit (CooperSurgical, Trumbull, CT) as previously described (Wong et al 2010). Briefly, cryocontainers were removed from liquid nitrogen and exposed to air for 10 sec before incubating in a water bath at 37 °C until thawed. Next, embryos were transferred to 0. The MTTH model of induced human naïve pluripotent cells was established and analyzed using the OCT4-Δ PE-GFP line exactly as previously described [18] . Individual gene overexpression and gene targeting experiments were performed as previously reported using previously characterized reagents and cell lines [17; 18] .
Statistical Analysis
For single-cell analysis individual cells were considered as biological replicates (n = 241 HPAT's expression-defined sub-populations of the early (Fig. 2F) and late ( Fig. 2G) blastocysts are shown.
The statistical significance of the observed expression changes between sub-populations or within a sub- 3 6 population during differentiation were estimated based on comparisons of the numbers of positive and negative cells using two-tailed Fisher's exact test. Stars designate sub-populations harboring the significantly different numbers of cells expressing defined genetic markers. P values reported in the Supplemental Table S2 . 
